ACCPL
Start SIP
Invest Now
Start SIP in ACCPL
Accretion Pharmaceuticals live price: ₹64.3. It opened at ₹65 vs previous close ₹67; intraday high/low: ₹65/₹63. The 50 & 200 DMA stand at ₹70.90/₹69.19.
Accretion Pharmaceuticals Performance
- Low
- ₹63
- High
- ₹65
- 52 Week Low
- ₹54
- 52 Week High
- ₹103
- Open Price₹65
- Previous Close₹67
- Volume20,400
- 50 DMA₹70.90
- 100 DMA₹71.75
- 200 DMA₹69.19
Investment Returns
- Over 1 Month -6.13%
- Over 3 Month -32.67%
- Over 6 Month + 2.8%
- Over 1 Year -36.34%
Smart Investing Starts Here Start SIP with Accretion Pharmaceuticals for Steady Growth!
Accretion Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 10.5
- PEG Ratio
- -
- Market Cap Cr
- 72
- P/B Ratio
- 1.5
- Average True Range
- 2.63
- EPS
- 6.11
- Dividend Yield
- 0
- MACD Signal
- -1.31
- RSI
- 40.68
- MFI
- 41.81
Accretion Pharmaceuticals Financials
Accretion Pharmaceuticals Technicals
EMA & SMA
Current Price
₹64.30
-2.4
(-3.6%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹68.17
- 50 Day
- ₹70.90
- 100 Day
- ₹71.75
- 200 Day
- ₹69.19
Resistance and Support
64.3
- R3 67.00
- R2 66.10
- R1 65.20
- S1 63.40
- S2 62.50
- S3 61.60
Accretion Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-06-10 | Audited Results & Others | To consider Other business matters. |
Accretion Pharmaceuticals F&O
About Accretion Pharmaceuticals
- NSE Symbol
- ACCPL
- BSE Symbol
- Managing Director
- Mr. Vivek Ashok Kumar Patel
- ISIN
- INE0T8T01010
Similar Stocks to Accretion Pharmaceuticals
Accretion Pharmaceuticals FAQs
Accretion Pharmaceuticals share price is ₹64 As on 15 March, 2026 | 14:08
The Market Cap of Accretion Pharmaceuticals is ₹71.5 Cr As on 15 March, 2026 | 14:08
The P/E ratio of Accretion Pharmaceuticals is 10.5 As on 15 March, 2026 | 14:08
The PB ratio of Accretion Pharmaceuticals is 1.5 As on 15 March, 2026 | 14:08
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.